Bergabunglah dengan Buletin Kami
Bergabunglah dengan daftar pelanggan kami untuk mendapatkan artikel terkini, update dan penawaran khusus langsung di kotak masuk Anda
Scientists developed a two-vector strategy for generating CAR T cells in vivo, w...
eXoZymes views Cayman’s pilot run as an important validation of its cell-free pl...
MilliporeSigma, the U.S. and Canadian Life sciences business of Merck KGaA, Darm...
Basecamp Research launched the Trillion Gene Atlas with partners to collect geno...
New Delhi: GlaxoSmithKline (GSK) Pharmaceuticals Limited has announced the resig...
Hyderabad: Ten employees sustained injuries after a pharmaceutical company's bus...
New Delhi: CureBay, a hybrid healthcare company focused on expanding access to q...
South Korea: A new study has revealed that there is a causal relationship betwee...
New Delhi: The Drugs Technical Advisory Board (DTAB), in its 93rd meeting, has ...
New Delhi: Zydus Lifesciences' wholly owned subsidiary Sentynl Therapeutics has ...
Reauthorization of federal seed funding, a top priority for BIO’s work with Cong...
A lack of production capacity for autologous CAR T therapies is limiting access....
A benchtop bioreactor protocol enables standardized intermediate-scale productio...
A new rheological technique combines imaging and continuous phase material desig...
When using the sandwich ELISA, HDX-MS combined with computational methods, such ...
Junior doctors in Kerala have expressed dissatisfaction over low, stagnant salar...
